4th Quarter - Report
W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP
Firm
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Education about innovative contracting and value based payments. Education about the 340(b) drug discount program including the CMS 340(b) CMP Rule.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
H.R.6642: "to sunset the limit on maximum rebate amount for single source drugs".
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Budget/Appropriations BUD
H.R.1892: Bipartisan Budget Act of 2018 as it relates to a Part D donut hole provision.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.